HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China
HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces tha...